bioAffinity Technologies, Inc. - 8-K Filing
bioAffinity Technologies reports record October testing volume and 109% year-to-date increase in CyPath Lung test unit sales for Q3 2026. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $BIAF
Read the full article at SEC EDGAR
Part of the story bioAffinity Technologies, Inc. - 8-K Filing (3 articles)